Genetic markers in breast cancer – how far fave we come from BRCA1?
Breast cancer is the most common malignancy that develops in women worldwide, its incidence continues to rise and it is responsible for the highest death rates. Breast cancer can be classified as sporadic or familial – the strongest risk factor today is a family history. Germline mutations in high...
Main Authors: | Avery-Kiejda, Kelly A., Wong, Michelle W., Scott, Rodney J. |
---|---|
Format: | Article |
Language: | English |
Published: |
UKM Medical Molecular biology Institute, UMBI
2011
|
Online Access: | http://journalarticle.ukm.my/3061/1/2011-1-3.pdf |
Similar Items
-
Genetic markers in breast cancer- How far have we come from BRCA1?
by: Avery-Kiejda KA,, et al.
Published: (2011) -
How far have we come?
by: Priscilla Robinson, et al.
Published: (2015-12-01) -
Nudge: How Far Have We Come?
by: Magda Osman
Published: (2016-12-01) -
Overcoming Shellfish Allergy: How Far Have We Come?
by: Christine Y.Y. Wai, et al.
Published: (2020-03-01) -
Immunotherapy in myeloma: how far have we come?
by: Laurens E. Franssen, et al.
Published: (2019-01-01)